We work with the medical community to transform the lives of patients through the best scientific, management and leadership talent worldwide.
OTC drug makers, private research institutes, device manufacturers and others across the life science spectrum benefit from Boyden’s specialised expertise in meeting distinct talent needs.
The survey aims to understand the outlook around demand and availability of executive talent, global mobility, time to recruit, remuneration and a breakdown of growth potential by sector.
Our discussion with Ray Pisani, President & CEO of Alberta Blue Cross on leadership, motivation, and the value of diversity.
Lower volumes, higher biotech industry costs, and the departure of big pharmaceutical companies from the field thwart development of new antibiotics.
By merging with Celgene in a record $74 billion deal, Bristol-Meyers will create a formidable organization in the competitive immunotherapy space.
Boyden’s Trevor Pritchard and Steve Nilsen placed Amy Efantis as new President and Chief Executive Officer of the Plasma Therapeutics Association (PPTA).